Jasper Debt Ratio from 2010 to 2024

JSPRW Stock

USD 0.20 0.01 5.26%

Jasper Therapeutics Debt Ratio yearly trend continues to be fairly stable with very little volatility. Debt Ratio will likely drop to 0.01 in 2024. During the period from 2010 to 2024, Jasper Therapeutics Debt Ratio regression line of quarterly data had mean square error of 0.00000882 and geometric mean of 0.01. View All Fundamentals

Debt Ratio

First Reported

2010-12-31

Previous Quarter

0.01024322

Current Value

0.00896

Quarterly Volatility

0.00341434

Credit Downgrade

Yuan Drop

Covid

Check Jasper Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jasper Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Selling General Administrative of 11.2 M or Other Operating Expenses of 40 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.1. Jasper financial statements analysis is a perfect complement when working with Jasper Therapeutics Valuation or Volatility modules.

Check out the analysis of Jasper Therapeutics Correlation against competitors.

For more information on how to buy Jasper Stock please use our How to Invest in Jasper Therapeutics guide.

Latest Jasper Therapeutics' Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of Jasper Therapeutics over the last few years. It is Jasper Therapeutics' Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jasper Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Debt Ratio

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Debt Ratio

Timeline

Jasper Debt Ratio Regression Statistics

	Arithmetic Mean	0.01
	Geometric Mean	0.01
	Coefficient Of Variation	50.31
	Mean Deviation	0
	Median	0.01
	Standard Deviation	0
	Sample Variance	0.000012
	Range	0.0125
	R-Value	0.55
	Mean Square Error	0.00000882
	R-Squared	0.30
	Significance	0.04
	Slope	0.0004
	Total Sum of Squares	0.0002

Jasper Debt Ratio History

	2024	0.00896
	2023	0.0102
	2022	0.0179

Other Fundumenentals of Jasper Therapeutics

Cash Flow To Debt Ratio

Jasper Therapeutics Debt Ratio component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Short Term Investments	Capital Surpluse	Total Liab	Long Term Investments	Total Current Assets	Common Stock	Long Term Debt	Net Receivables	Long Term Debt Total	Net Invested Capital	Capital Stock	Net Working Capital	Current Deferred Revenue	Short Term Debt
Total Assets		0.83	-0.78	-0.96	-0.81	0.98	-0.53	0.77	0.29	0.7	1.0	-0.7	-0.53	-0.74	-0.53	0.97	0.58	1.0	-0.53	0.66
Total Stockholder Equity	0.83		-0.59	-0.9	-0.73	0.73	-0.68	0.38	-0.18	0.69	0.84	-0.39	-0.68	-0.7	-0.68	0.82	0.45	0.83	-0.68	0.66
Net Tangible Assets	-0.78	-0.59		0.8	0.96	-0.86	0.76	-0.89	-0.63	-0.77	-0.75	0.97	0.76	0.71	0.76	-0.85	-0.49	-0.82	0.76	-0.82
Net Debt	-0.96	-0.9	0.8		0.84	-0.93	0.72	-0.66	-0.23	-0.77	-0.96	0.68	0.72	0.81	0.72	-0.92	-0.48	-0.97	0.72	-0.66
Retained Earnings	-0.81	-0.73	0.96	0.84		-0.85	0.81	-0.81	-0.39	-0.86	-0.79	0.87	0.81	0.78	0.81	-0.89	-0.46	-0.83	0.81	-0.94
Accounts Payable	0.98	0.73	-0.86	-0.93	-0.85		-0.55	0.87	0.48	0.71	0.97	-0.82	-0.55	-0.75	-0.55	0.96	0.56	0.98	-0.55	0.67
Short Term Investments	-0.53	-0.68	0.76	0.72	0.81	-0.55		-0.39	-0.19	-0.85	-0.53	0.63	1.0	0.77	1.0	-0.57	-0.07	-0.58	1.0	-0.73
Capital Surpluse	0.77	0.38	-0.89	-0.66	-0.81	0.87	-0.39		0.74	0.56	0.74	-0.94	-0.39	-0.53	-0.39	0.84	0.6	0.78	-0.39	0.69
Total Liab	0.29	-0.18	-0.63	-0.23	-0.39	0.48	-0.19	0.74		0.2	0.26	-0.79	-0.19	-0.2	-0.19	0.33	0.25	0.34	-0.19	0.19
Long Term Investments	0.7	0.69	-0.77	-0.77	-0.86	0.71	-0.85	0.56	0.2		0.7	-0.66	-0.85	-0.97	-0.85	0.7	-0.01	0.7	-0.85	0.83
Total Current Assets	1.0	0.84	-0.75	-0.96	-0.79	0.97	-0.53	0.74	0.26	0.7		-0.66	-0.53	-0.75	-0.53	0.96	0.55	0.99	-0.53	0.63
Common Stock	-0.7	-0.39	0.97	0.68	0.87	-0.82	0.63	-0.94	-0.79	-0.66	-0.66		0.63	0.61	0.63	-0.77	-0.46	-0.73	0.63	-0.72
Long Term Debt	-0.53	-0.68	0.76	0.72	0.81	-0.55	1.0	-0.39	-0.19	-0.85	-0.53	0.63		0.77	1.0	-0.57	-0.07	-0.58	1.0	-0.73
Net Receivables	-0.74	-0.7	0.71	0.81	0.78	-0.75	0.77	-0.53	-0.2	-0.97	-0.75	0.61	0.77		0.77	-0.69	0.06	-0.74	0.77	-0.7
Long Term Debt Total	-0.53	-0.68	0.76	0.72	0.81	-0.55	1.0	-0.39	-0.19	-0.85	-0.53	0.63	1.0	0.77		-0.57	-0.07	-0.58	1.0	-0.73
Net Invested Capital	0.97	0.82	-0.85	-0.92	-0.89	0.96	-0.57	0.84	0.33	0.7	0.96	-0.77	-0.57	-0.69	-0.57		0.68	0.97	-0.57	0.78
Capital Stock	0.58	0.45	-0.49	-0.48	-0.46	0.56	-0.07	0.6	0.25	-0.01	0.55	-0.46	-0.07	0.06	-0.07	0.68		0.59	-0.07	0.36
Net Working Capital	1.0	0.83	-0.82	-0.97	-0.83	0.98	-0.58	0.78	0.34	0.7	0.99	-0.73	-0.58	-0.74	-0.58	0.97	0.59		-0.58	0.65
Current Deferred Revenue	-0.53	-0.68	0.76	0.72	0.81	-0.55	1.0	-0.39	-0.19	-0.85	-0.53	0.63	1.0	0.77	1.0	-0.57	-0.07	-0.58		-0.73
Short Term Debt	0.66	0.66	-0.82	-0.66	-0.94	0.67	-0.73	0.69	0.19	0.83	0.63	-0.72	-0.73	-0.7	-0.73	0.78	0.36	0.65	-0.73

Click cells to compare fundamentals

About Jasper Therapeutics Financial Statements

Jasper Therapeutics investors use historical fundamental indicators, such as Jasper Therapeutics' Debt Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jasper Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Debt Ratio	0.01	0.01
Cash Flow To Debt Ratio	(53.57)	(56.25)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Jasper Debt Ratio from 2010 to 2024

Latest Jasper Therapeutics' Debt Ratio Growth Pattern

Jasper Debt Ratio Regression Statistics

Jasper Debt Ratio History

Other Fundumenentals of Jasper Therapeutics

Jasper Therapeutics Debt Ratio component correlations

About Jasper Therapeutics Financial Statements

Also Currently Popular

Additional Tools for Jasper Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY